Role of aldosterone in the control of sodium excretion in patients with advanced chronic renal failure - PubMed (original) (raw)
Role of aldosterone in the control of sodium excretion in patients with advanced chronic renal failure
T Berl et al. Kidney Int. 1978 Sep.
Free article
No abstract available
Similar articles
- Influence of aldosterone on sodium, water and potassium metabolism in chronic renal disease.
Schrier RW, Regal EM. Schrier RW, et al. Kidney Int. 1972 Mar;1(3):156-68. doi: 10.1038/ki.1972.23. Kidney Int. 1972. PMID: 4671219 No abstract available. - The renal regulation of sodium and potassium in patients with chronic renal failure (CRF) and the effect of diuretics on the excretion of these ions.
Kleeman CR, Okun R, Heller RJ. Kleeman CR, et al. Ann N Y Acad Sci. 1966 Nov 22;139(2):520-39. doi: 10.1111/j.1749-6632.1966.tb41226.x. Ann N Y Acad Sci. 1966. PMID: 5230293 No abstract available. - Role of aldosterone in the sodium retention of patients with nephrotic syndrome.
Shapiro MD, Hasbargen J, Hensen J, Schrier RW. Shapiro MD, et al. Am J Nephrol. 1990;10(1):44-8. doi: 10.1159/000168052. Am J Nephrol. 1990. PMID: 2188506 - Secondary aldosteronism.
Corry DB, Tuck ML. Corry DB, et al. Endocrinol Metab Clin North Am. 1995 Sep;24(3):511-29. Endocrinol Metab Clin North Am. 1995. PMID: 8575407 Review. - [Role of aldosterone in the pathogenesis of cardiac insufficiency (review of the literature)].
Vinogradov AV, Sycheva IM. Vinogradov AV, et al. Kardiologiia. 1967 Feb;7(2):89-93. Kardiologiia. 1967. PMID: 4884838 Review. Russian. No abstract available.
Cited by
- Evolution of Mineralocorticoid Receptor Antagonists in the Treatment of Chronic Kidney Disease Associated with Type 2 Diabetes Mellitus.
Wish JB, Pergola P. Wish JB, et al. Mayo Clin Proc Innov Qual Outcomes. 2022 Oct 15;6(6):536-551. doi: 10.1016/j.mayocpiqo.2022.09.002. eCollection 2022 Dec. Mayo Clin Proc Innov Qual Outcomes. 2022. PMID: 36277502 Free PMC article. Review. - A Comparison of Urine Dilution Ability between Adult Dominant Polycystic Kidney Disease, Other Chronic Kidney Diseases, and Healthy Control Subjects: A Case-Control Study.
Malmberg MH, Mose FH, Pedersen EB, Bech JN. Malmberg MH, et al. Int J Nephrol. 2020 Dec 2;2020:4108418. doi: 10.1155/2020/4108418. eCollection 2020. Int J Nephrol. 2020. PMID: 33343937 Free PMC article. - The effect of aldosterone and aldosterone blockade on the progression of chronic kidney disease: a randomized placebo-controlled clinical trial.
Minakuchi H, Wakino S, Urai H, Kurokochi A, Hasegawa K, Kanda T, Tokuyama H, Itoh H. Minakuchi H, et al. Sci Rep. 2020 Oct 6;10(1):16626. doi: 10.1038/s41598-020-73638-4. Sci Rep. 2020. PMID: 33024237 Free PMC article. Clinical Trial.